231 related articles for article (PubMed ID: 38139847)
1. The Impact of Sex on the Response to Proton Pump Inhibitor Treatment.
Helgadottir H; Björnsson ES
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139847
[TBL] [Abstract][Full Text] [Related]
2. Problems Associated with Deprescribing of Proton Pump Inhibitors.
Helgadottir H; Bjornsson ES
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
[TBL] [Abstract][Full Text] [Related]
3. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
[TBL] [Abstract][Full Text] [Related]
4. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
6. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
Waldum HL; Sørdal Ø; Fossmark R
Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
[TBL] [Abstract][Full Text] [Related]
9. Overutilization of proton-pump inhibitors: what the clinician needs to know.
Heidelbaugh JJ; Kim AH; Chang R; Walker PC
Therap Adv Gastroenterol; 2012 Jul; 5(4):219-32. PubMed ID: 22778788
[TBL] [Abstract][Full Text] [Related]
10. Safety of the long-term use of proton pump inhibitors.
Thomson AB; Sauve MD; Kassam N; Kamitakahara H
World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
[TBL] [Abstract][Full Text] [Related]
11. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin.
Han YM; Park JM; Kangwan N; Jeong M; Lee S; Cho JY; Ko WJ; Hahm KB
J Physiol Pharmacol; 2015 Apr; 66(2):159-67. PubMed ID: 25903947
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of single and repeated oral doses of esomeprazole and gastrin elevation in healthy males and females.
Helgadóttir H; Lund SH; Gizurarson S; Waldum H; Björnsson ES
Scand J Gastroenterol; 2021 Feb; 56(2):128-136. PubMed ID: 33327801
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.
Helgadóttir H; Lund SH; Gizurarson S; Metz DC; Björnsson ES
J Clin Gastroenterol; 2020 Mar; 54(3):227-234. PubMed ID: 30994520
[TBL] [Abstract][Full Text] [Related]
14. Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized Trial.
Helgadóttir H; Metz DC; Lund SH; Gizurarson S; Jacobsen EI; Asgeirsdóttir GA; Yngadóttir Y; Björnsson ES
J Clin Gastroenterol; 2017 Jul; 51(6):486-493. PubMed ID: 27159420
[TBL] [Abstract][Full Text] [Related]
15. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
16. Influence of proton pump inhibitor use in gastrointestinal polyps.
Hsu WH; Wu IC; Kuo CH; Su YC; Lu CY; Kuo FC; Jan CM; Wang WM; Wu DC; Yu FJ
Kaohsiung J Med Sci; 2010 Feb; 26(2):76-83. PubMed ID: 20123595
[TBL] [Abstract][Full Text] [Related]
17. Gastric epithelial cell modality and proton pump inhibitor.
Masaoka T; Suzuki H; Hibi T
J Clin Biochem Nutr; 2008 May; 42(3):191-6. PubMed ID: 18545640
[TBL] [Abstract][Full Text] [Related]
18. [Current use of proton pump inhibitors and when to limit, stop or not start treatment].
Helgadottir H; Bjornsson ES
Laeknabladid; 2023 Jul; 109(708):338-345. PubMed ID: 37378651
[TBL] [Abstract][Full Text] [Related]
19. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L; Ramos-Alvarez I; Ito T; Jensen RT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
[TBL] [Abstract][Full Text] [Related]
20. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
